ATRenew Sees Q2 Sales $900.861M-$915.298M vs $927.170M Est

Benzinga Newsdesk www.benzinga.com Positive 81.3%

Neg 0% Neu 0% Pos 81.3%

ATRenew (NYSE:RERE) sees Q2 sales of $900.861 million-$915.298 million vs $927.170 million analyst estimate.

Comments

No comments yet. Be the first!